$BHC
Bausch Health Companies Inc.

2016 Q4 Form 10-Q Financial Statement

#000088559016000124 Filed on November 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $2.403B $2.479B $2.787B
YoY Change -12.87% -11.05% 36.4%
Cost Of Revenue $665.3M $649.0M $634.6M
YoY Change -1.68% 2.27% 16.27%
Gross Profit $1.737B $1.830B $2.152B
YoY Change -15.65% -14.98% 43.73%
Gross Profit Margin 72.3% 73.82% 77.23%
Selling, General & Admin $665.0M $661.0M $697.6M
YoY Change -10.49% -5.25% 38.39%
% of Gross Profit 38.28% 36.12% 32.41%
Research & Development $92.80M $101.0M $101.6M
YoY Change -3.23% -0.59% 71.91%
% of Gross Profit 5.34% 5.52% 4.72%
Depreciation & Amortization $707.0M $708.0M $726.4M
YoY Change 1.2% -2.53% 65.35%
% of Gross Profit 40.7% 38.69% 33.75%
Operating Expenses $1.136B $762.0M $799.2M
YoY Change -31.98% -4.65% 41.9%
Operating Profit $150.0M -$863.0M $448.0M
YoY Change -10.71% -292.63% -33.29%
Interest Expense -$510.4M -$469.4M -$453.5M
YoY Change 17.33% 3.51% 47.62%
% of Operating Profit -340.27% -101.23%
Other Income/Expense, Net -$1.000M
YoY Change
Pretax Income -$360.1M -$1.332B -$5.700M
YoY Change 49.85% 23268.42% -101.51%
Income Tax $151.9M -$113.0M -$57.40M
% Of Pretax Income
Net Earnings -$514.6M -$1.219B $51.70M
YoY Change 42.19% -2457.83% -81.3%
Net Earnings / Revenue -21.41% -49.17% 1.86%
Basic Earnings Per Share -$1.47 -$3.49 $0.14
Diluted Earnings Per Share -$1.47 -$3.49 $0.14
COMMON SHARES
Basic Shares Outstanding 347.7M shares 349.5M shares 344.9M shares
Diluted Shares Outstanding 349.5M shares 351.0M shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $542.0M $659.0M $1.420B
YoY Change -9.21% -53.59% 75.53%
Cash & Equivalents $542.0M $659.0M $1.420B
Short-Term Investments
Other Short-Term Assets $957.0M $1.007B $1.680B
YoY Change -0.93% -40.06% 112.12%
Inventory $1.061B $1.300B $1.199B
Prepaid Expenses
Receivables $2.517B $2.708B $2.696B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.077B $5.674B $6.996B
YoY Change -7.81% -18.9% 58.5%
LONG-TERM ASSETS
Property, Plant & Equipment $1.312B $1.462B $1.351B
YoY Change -9.02% 8.18% 3.92%
Goodwill $15.79B $17.45B $17.37B
YoY Change -14.87% 0.43% 83.51%
Intangibles $18.88B $20.51B $22.38B
YoY Change -18.19% -8.37% 92.61%
Long-Term Investments
YoY Change
Other Assets $184.0M $213.6M $236.1M
YoY Change -17.86% -9.53% 1.16%
Total Long-Term Assets $38.45B $40.09B $41.46B
YoY Change -11.52% -3.31% 83.07%
TOTAL ASSETS
Total Short-Term Assets $5.077B $5.674B $6.996B
Total Long-Term Assets $38.45B $40.09B $41.46B
Total Assets $43.53B $45.76B $48.45B
YoY Change -11.1% -5.56% 79.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $324.0M $358.7M $476.8M
YoY Change -25.35% -24.77% 47.48%
Accrued Expenses $3.227B $3.392B $3.294B
YoY Change -16.38% 2.98% 65.18%
Deferred Revenue
YoY Change
Short-Term Debt $6.000M $0.00 $0.00
YoY Change -62.5%
Long-Term Debt Due $1.000M $59.00M $707.0M
YoY Change -99.88% -91.65% 2.37%
Total Short-Term Liabilities $3.609B $3.897B $4.651B
YoY Change -32.07% -16.21% 47.95%
LONG-TERM LIABILITIES
Long-Term Debt $29.85B $30.39B $30.18B
YoY Change -1.39% 0.7% 93.63%
Other Long-Term Liabilities $486.0M $165.0M $209.1M
YoY Change 162.7% -21.09% 0.24%
Total Long-Term Liabilities $30.33B $30.55B $30.39B
YoY Change -0.39% 0.55% 92.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.609B $3.897B $4.651B
Total Long-Term Liabilities $30.33B $30.55B $30.39B
Total Liabilities $40.27B $41.49B $41.99B
YoY Change -6.21% -1.2% 92.38%
SHAREHOLDERS EQUITY
Retained Earnings -$5.129B -$4.614B -$2.339B
YoY Change 86.51% 97.31% -19.36%
Common Stock $10.39B $10.36B $10.14B
YoY Change 1.83% 2.13% 18.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.152B $4.167B $6.342B
YoY Change
Total Liabilities & Shareholders Equity $43.53B $45.76B $48.45B
YoY Change -11.1% -5.56% 79.07%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$514.6M -$1.219B $51.70M
YoY Change 42.19% -2457.83% -81.3%
Depreciation, Depletion And Amortization $707.0M $708.0M $726.4M
YoY Change 1.2% -2.53% 65.35%
Cash From Operating Activities $512.0M $569.0M $733.0M
YoY Change -14.38% -22.37% 18.47%
INVESTING ACTIVITIES
Capital Expenditures -$62.00M -$91.00M $51.10M
YoY Change -23.65% -278.08% 29.04%
Acquisitions $115.8M
YoY Change -80.92%
Other Investing Activities $68.00M $22.00M -$105.0M
YoY Change -104.68% -120.95% -112.07%
Cash From Investing Activities $6.000M -$69.00M -$156.2M
YoY Change -100.39% -55.83% -120.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $29.00M
YoY Change -98.22%
Cash From Financing Activities -575.0M -697.0M -$108.5M
YoY Change -569.39% 542.4% -89.97%
NET CHANGE
Cash From Operating Activities $512.0M $569.0M $733.0M
Cash From Investing Activities 6.000M -69.00M -$156.2M
Cash From Financing Activities -575.0M -697.0M -$108.5M
Net Change In Cash $512.0M $569.0M $468.3M
YoY Change -14.38% 21.5% 59.88%
FREE CASH FLOW
Cash From Operating Activities $512.0M $569.0M $733.0M
Capital Expenditures -$62.00M -$91.00M $51.10M
Free Cash Flow $574.0M $660.0M $681.9M
YoY Change -15.49% -3.21% 17.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000885590
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
700000 USD
dei Entity Registrant Name
EntityRegistrantName
Valeant Pharmaceuticals International, Inc.
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
347669858 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50500000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
433700000 USD
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
358700000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3859100000 USD
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3391800000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-915900000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1463400000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1541600000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1578900000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
304900000 USD
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
325900000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
21700000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111400000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
134000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
111400000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36800000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134000000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
123700000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
89200000 USD
CY2015Q4 us-gaap Assets
Assets
48964500000 USD
CY2016Q3 us-gaap Assets
Assets
45761200000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
5507200000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
5673800000 USD
CY2015Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.16
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.71
CY2015Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.16
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.71
CY2015Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
56200000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-243700000 USD
CY2015Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2862100000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7938300000 USD
CY2015Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7000000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
30400000 USD
CY2016Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1800000 USD
CY2015Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-3800000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-22600000 USD
CY2016Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-9000000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-18300000 USD
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
196800000 USD
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
87300000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
322600000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1420000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
597300000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
658500000 USD
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
342926531 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
347669423 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
342926531 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1097400000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
61200000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
30200000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347669423 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
9897400000 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
10034400000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-122400000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-453300000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1223600000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1931700000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
400000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2200000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-900000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3400000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-122000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-451100000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1224500000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1935100000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
634600000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1812400000 USD
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
649200000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1916700000 USD
CY2015Q3 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
13600000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
43100000 USD
CY2016Q3 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
8800000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
29000000 USD
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
2339000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6329000000 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
3342600000 USD
us-gaap Costs And Expenses
CostsAndExpenses
7987700000 USD
CY2015Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
30000000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-18400000 USD
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
156000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
452300000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1370000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1900000000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-96600000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
14600000 USD
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5902400000 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5839000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1768400000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2532500000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.47
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.47
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-22000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
6400000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7411600000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9350200000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2672800000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2133900000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2341400000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2468100000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2597100000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28186700000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27899500000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20775100000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18549300000 USD
CY2015Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-34000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-99500000 USD
CY2016Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2300000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4600000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-9200000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
11000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-31900000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
32100000 USD
CY2015Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20000000 USD
CY2016Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2015Q4 us-gaap Goodwill
Goodwill
18552800000 USD
CY2016Q3 us-gaap Goodwill
Goodwill
17450100000 USD
CY2015Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1049000000 USD
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1049000000 USD
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1050000000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1049000000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-36200000 USD
CY2015Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
79000000 USD
CY2016Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
16000000 USD
CY2016Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
215000000 USD
CY2016Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
142000000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
112600000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1332400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2074900000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-57400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-113000000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-113300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-178900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-179000000 USD
us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
32000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
344700000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29200000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
656000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30900000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
184900000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
166300000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
252000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-117700000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
5200000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6100000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6400000 shares
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
30494600000 USD
CY2016Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
29859600000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23083000000 USD
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20509400000 USD
CY2015Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
420200000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1130700000 USD
CY2016Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
469600000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1368700000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
814600000 USD
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
816900000 USD
CY2015Q4 us-gaap Inventory Gross
InventoryGross
1256600000 USD
CY2016Q3 us-gaap Inventory Gross
InventoryGross
1300100000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
1256600000 USD
CY2016Q3 us-gaap Inventory Net
InventoryNet
1300100000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
289300000 USD
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
351400000 USD
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
152700000 USD
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
131800000 USD
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
700000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2500000 USD
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2500000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
5500000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
42934700000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
41487600000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48964500000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45761200000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5312600000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3896800000 USD
CY2015Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
120200000 USD
CY2016Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
112300000 USD
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
31088400000 USD
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
31090000000 USD
CY2016Q3 us-gaap Long Term Debt
LongTermDebt
30445200000 USD
CY2016Q3 us-gaap Long Term Debt
LongTermDebt
30450000000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
823000000 USD
CY2016Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
59000000 USD
CY2015Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
29600000000 USD
CY2016Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
28850000000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30265400000 USD
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30386200000 USD
CY2015Q4 us-gaap Minority Interest
MinorityInterest
118800000 USD
CY2016Q3 us-gaap Minority Interest
MinorityInterest
106300000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
7000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13501500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1388300000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14041900000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-131400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1659800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1574500000 USD
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2200000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4400000 USD
CY2016Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-700000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1600000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49500000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
94200000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1218400000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1894400000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
3129200000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 USD
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
4900000 USD
CY2016Q3 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
100 country
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2016Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2016Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
447800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1360300000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-863000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-716300000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
223700000 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
213600000 USD
CY2015Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
500000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
1400000 USD
CY2016Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
600000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
1600000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-546100000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-35700000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-173200000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-548300000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4800000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37500000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-173700000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-549700000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39100000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1400000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1600000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
184600000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
165000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
13600000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
12200000 USD
CY2015Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-30200000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-213200000 USD
CY2016Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1100000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
21600000 USD
CY2015Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
38600000 USD
CY2016Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
36000000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
120000000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
103000000 USD
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
26300000 USD
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
32100000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
67800000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
101700000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
96400000 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
18000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
85800000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9100000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14001700000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18500000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
58100000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
48100000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24500000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1400000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
163700000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
181100000 USD
CY2015Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
190400000 USD
CY2016Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
190300000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
966400000 USD
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1006800000 USD
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
184600000 USD
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1433700000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
16925800000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1219900000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-10000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8100000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
50200000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
16500000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2800000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
131400000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
6900000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2700000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29100000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33100000 USD
CY2015Q3 us-gaap Profit Loss
ProfitLoss
51700000 USD
us-gaap Profit Loss
ProfitLoss
98600000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-1219100000 USD
us-gaap Profit Loss
ProfitLoss
-1896000000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1441800000 USD
CY2016Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
2708400000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1462000000 USD
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2686900000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3122800000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1387200000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1920000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1917100000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
7100000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2800000 USD
CY2015Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
101600000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
238500000 USD
CY2016Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
100800000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
328200000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
108100000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
20000000 USD
CY2015Q3 us-gaap Restructuring Charges
RestructuringCharges
75600000 USD
us-gaap Restructuring Charges
RestructuringCharges
274000000 USD
CY2016Q3 us-gaap Restructuring Charges
RestructuringCharges
20700000 USD
us-gaap Restructuring Charges
RestructuringCharges
78200000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2749700000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4614100000 USD
CY2015Q3 us-gaap Revenues
Revenues
2786800000 USD
us-gaap Revenues
Revenues
7689300000 USD
CY2016Q3 us-gaap Revenues
Revenues
2479600000 USD
us-gaap Revenues
Revenues
7271400000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2748200000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7569300000 USD
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2443600000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7168400000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
697600000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1956900000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
660900000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2145000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
111400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
134000000 USD
CY2016Q2 us-gaap Stock Issued1
StockIssued1
50000000 USD
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7286432 shares
CY2016Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
213610 shares
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1450000000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1481000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29100000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
33100000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
5911000000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
4167300000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5401700000 USD
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6455900000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6029800000 USD
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4273600000 USD
CY2015Q4 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
23000000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
7000000 USD
CY2016Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
5000000 USD
CY2016Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
47000000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
46000000 USD
CY2016Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
42000000 USD
CY2016Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
123000000 USD
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
351000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
347200000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
349500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
346500000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
340800000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
349500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
346500000 shares
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
97700000 USD
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
38100000 USD
vrx Adjustmentto Additional Paidin Capital Employee Withholding Taxes Relatedto Sharebased Awards
AdjustmenttoAdditionalPaidinCapitalEmployeeWithholdingTaxesRelatedtoSharebasedAwards
85800000 USD
vrx Adjustmentto Additional Paidin Capital Employee Withholding Taxes Relatedto Sharebased Awards
AdjustmenttoAdditionalPaidinCapitalEmployeeWithholdingTaxesRelatedtoSharebasedAwards
9100000 USD
CY2015Q2 vrx Allocated Sharebase Compensation Expense Reversal
AllocatedSharebaseCompensationExpenseReversal
6000000 USD
CY2015 vrx Allocated Sharebased Compensation Expense Relatedto Modified Awards
AllocatedSharebasedCompensationExpenseRelatedtoModifiedAwards
12000000 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
46400000 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
95900000 USD
CY2015Q3 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
679200000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
1629800000 USD
CY2016Q3 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
807100000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
2389200000 USD
vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
744500000 USD
vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
0 USD
CY2015Q3 vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
25000000 USD
vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
94000000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
22600000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
18300000 USD
CY2015Q4 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
959100000 USD
CY2016Q3 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
898000000 USD
vrx Decreaseto Fair Valueof Reporting Units Hypothetical Percentage
DecreasetoFairValueofReportingUnitsHypotheticalPercentage
0.15
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-61100000 USD
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-310300000 USD
vrx Fair Value Assets Level1to Level2 Transfers Value
FairValueAssetsLevel1toLevel2TransfersValue
0 USD
vrx Highly Liquid Investments Maturity Period
HighlyLiquidInvestmentsMaturityPeriod
P3M
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
19800000 USD
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
26600000 USD
vrx Paymentof Deferred Consideration
PaymentofDeferredConsideration
0 USD
vrx Paymentof Deferred Consideration
PaymentofDeferredConsideration
516600000 USD
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
129400000 USD
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
93900000 USD
CY2016Q3 vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
350300000 shares
vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
349900000 shares
CY2015Q3 vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
95800000 USD
vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
108100000 USD
CY2016Q3 vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
36000000 USD
vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
53900000 USD
CY2015Q1 vrx Saleof Stock Public Offering Price Per Share
SaleofStockPublicOfferingPricePerShare
199.00
CY2015Q1 vrx Sharebased Compensation Arrangementby Sharebased Payment Award Additional Purchase Optionasa Percentageof Shares Issuedin Ipo Maximum
SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalPurchaseOptionasaPercentageofSharesIssuedinIPOMaximum
0.15
CY2015Q3 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
6907000000 USD
CY2016Q3 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
6208700000 USD
CY2016Q3 vrx Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
341000000 USD
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform to the current year presentation. Such amounts include a reclassification of </font><font style="font-family:inherit;font-size:10pt;">$14 million</font><font style="font-family:inherit;font-size:10pt;"> related to a change in income taxes payable that increased deferred income taxes and decreased accounts payable, accrued and other liabilities within changes in operating assets and liabilities within cash flow from operating activities of the Consolidated Statements of Cash Flows for the </font><font style="font-family:inherit;font-size:10pt;">nine-month period ended September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div>
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valeant Pharmaceuticals International, Inc. (the &#8220;Company&#8221;) is a multinational, specialty pharmaceutical and medical device company, continued under the laws of the Province of British Columbia, that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (&#8220;OTC&#8221;) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the unaudited consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the operating results for the interim periods presented are not necessarily indicative of the results expected for the full&#160;year.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company&#8217;s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company&#8217;s results of operations and financial position could be materially impacted.</font></div></div>

Files In Submission

Name View Source Status
0000885590-16-000124-index-headers.html Edgar Link pending
0000885590-16-000124-index.html Edgar Link pending
0000885590-16-000124.txt Edgar Link pending
0000885590-16-000124-xbrl.zip Edgar Link pending
exhibit311q32016.htm Edgar Link pending
exhibit312q32016.htm Edgar Link pending
exhibit321q32016.htm Edgar Link pending
exhibit322q32016.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
valeantq32016.htm Edgar Link pending
vrx-20160930.xml Edgar Link completed
vrx-20160930.xsd Edgar Link pending
vrx-20160930_cal.xml Edgar Link unprocessable
vrx-20160930_def.xml Edgar Link unprocessable
vrx-20160930_lab.xml Edgar Link unprocessable
vrx-20160930_pre.xml Edgar Link unprocessable